Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update

39Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Liver fibrosis is a life-threatening disease, with challenging morbidity and mortality for healthcare systems worldwide. It imparts an enormous economic burden to societies, making continuous research and informational updates about its pathogenesis and treatment crucial. This review′s focus is on the current knowledge about the Wnt signaling pathway, serving as an important pathway in liver fibrosis development and activation of hepatic stellate cells (HSCs).

Cite

CITATION STYLE

APA

Duspara, K., Bojanic, K., Pejic, J. I., Kuna, L., Kolaric, T. O., Nincevic, V., … Smolic, M. (2021). Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update. Journal of Clinical and Translational Hepatology. Xia and He Publishing Inc. https://doi.org/10.14218/JCTH.2021.00065

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free